标题
RAF kinase dimerization: implications for drug discovery and clinical outcomes
作者
关键词
-
出版物
ONCOGENE
Volume 39, Issue 21, Pages 4155-4169
出版商
Springer Science and Business Media LLC
发表日期
2020-04-09
DOI
10.1038/s41388-020-1263-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Analyses of the oncogenic BRAFD594G variant reveal a kinase-independent function of BRAF in activating MAPK signaling
- (2020) Nicholas J. Cope et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design and Synthesis of Type-IV Inhibitors of BRAF Kinase That Block Dimerization and Overcome Paradoxical MEK/ERK Activation
- (2019) Chad M. Beneker et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Allosteric BRAF Peptide Inhibitors Targeting the Dimer Interface of BRAF
- (2019) Amber Y. Gunderwala et al. ACS Chemical Biology
- ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor
- (2019) Dong Li et al. NATURE MEDICINE
- Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
- (2019) Christopher A. Eide et al. CANCER CELL
- Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains
- (2019) Florian Weinberg et al. ONCOGENE
- Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases
- (2019) Yasushi Kondo et al. SCIENCE
- Architecture of autoinhibited and active BRAF–MEK1–14-3-3 complexes
- (2019) Eunyoung Park et al. NATURE
- Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses
- (2019) Thomas Botton et al. Cell Reports
- Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling
- (2019) Elizabeth M. Terrell et al. MOLECULAR CELL
- Current Insights of BRAF Inhibitors in Cancer
- (2018) Bogos Agianian et al. JOURNAL OF MEDICINAL CHEMISTRY
- MEK drives BRAF activation through allosteric control of KSR proteins
- (2018) Hugo Lavoie et al. NATURE
- A treatment strategy for KRAS-driven tumors
- (2018) Trang T. Mai et al. NATURE MEDICINE
- BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines
- (2018) Ricarda Herr et al. ONCOGENE
- Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations
- (2018) Matthew Dankner et al. ONCOGENE
- The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutants
- (2018) Jimin Yuan et al. ONCOGENE
- Ras-Mediated Activation of the Raf Family Kinases
- (2018) Elizabeth M. Terrell et al. Cold Spring Harbor Perspectives in Medicine
- Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS Signaling
- (2018) Oleksii S. Rukhlenko et al. Cell Systems
- Allosteric activation of RAF in the MAPK signaling pathway
- (2018) Chung-Jung Tsai et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Proceedings of the fifth international RASopathies symposium: When development and cancer intersect
- (2018) Katherine A. Rauen et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling
- (2018) Zhan Yao et al. NATURE MEDICINE
- A compendium of ERK targets
- (2017) Evrim B. Ünal et al. FEBS LETTERS
- Phosphorylation of the C-Raf N Region Promotes Raf Dimerization
- (2017) Maho Takahashi et al. MOLECULAR AND CELLULAR BIOLOGY
- Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
- (2017) Zhan Yao et al. NATURE
- CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles
- (2017) P Jain et al. ONCOGENE
- BRAF inhibition in hairy cell leukemia with low-dose vemurafenib
- (2016) S. Dietrich et al. BLOOD
- Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2
- (2016) Scott A. Foster et al. CANCER CELL
- An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling
- (2016) Zoi Karoulia et al. CANCER CELL
- Regulation of BRAF protein stability by a negative feedback loop involving the MEK–ERK pathway but not the FBXW7 tumour suppressor
- (2016) Maria Aguilar Hernandez et al. CELLULAR SIGNALLING
- Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120
- (2016) S.-H. Chen et al. Cancer Discovery
- Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles
- (2016) Anja E. Eisenhardt et al. Oncotarget
- Phosphorylation of RAF Kinase Dimers Drives Conformational Changes that Facilitate Transactivation
- (2015) Pablo G. Jambrina et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers
- (2015) Sheng-Bin Peng et al. CANCER CELL
- BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition
- (2015) Zhan Yao et al. CANCER CELL
- Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutants
- (2015) M. Ko hler et al. EMBO JOURNAL
- The distribution ofBRAFgene fusions in solid tumors and response to targeted therapy
- (2015) Jeffrey S. Ross et al. INTERNATIONAL JOURNAL OF CANCER
- The Effect of a Widespread Cancer-Causing Mutation on the Inactive to Active Dynamics of the B-Raf Kinase
- (2015) Kristen A. Marino et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling
- (2015) M Kordes et al. LEUKEMIA
- Regulation of RAF protein kinases in ERK signalling
- (2015) Hugo Lavoie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
- (2015) E. L. Diamond et al. Cancer Discovery
- Drug Resistance Resulting from Kinase Dimerization Is Rationalized by Thermodynamic Factors Describing Allosteric Inhibitor Effects
- (2015) Boris N. Kholodenko Cell Reports
- Molecular mechanisms of asymmetric RAF dimer activation
- (2014) Pablo G. Jambrina et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Kinase Regulation by Hydrophobic Spine Assembly in Cancer
- (2014) Jiancheng Hu et al. MOLECULAR AND CELLULAR BIOLOGY
- Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation
- (2014) Neroshan Thevakumaran et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer
- (2014) L. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration
- (2014) J. Mooz et al. Science Signaling
- Allosteric Activation of Functionally Asymmetric RAF Kinase Dimers
- (2013) Jiancheng Hu et al. CELL
- Effects of Raf Dimerization and Its Inhibition on Normal and Disease-Associated Raf Signaling
- (2013) Alyson K. Freeman et al. MOLECULAR CELL
- Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
- (2013) David T W Jones et al. NATURE GENETICS
- Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas
- (2013) A. J. Sievert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling
- (2012) Michael Röring et al. EMBO JOURNAL
- Increased BRAF Heterodimerization Is the Common Pathogenic Mechanism for Noonan Syndrome-Associated RAF1 Mutants
- (2012) X. Wu et al. MOLECULAR AND CELLULAR BIOLOGY
- Mechanisms of acquired resistance to ERK1/2 pathway inhibitors
- (2012) A S Little et al. ONCOGENE
- Single Substitution within the RKTR Motif Impairs Kinase Activity but Promotes Dimerization of RAF Kinase
- (2011) Angela Baljuls et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF
- (2011) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- A dimerization-dependent mechanism drives RAF catalytic activation
- (2009) Thanashan Rajakulendran et al. NATURE
- Characterization of Ser338Phosphorylation for Raf-1 Activation
- (2008) Mengwei Zang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now